Professor
Gladstone Institutes, UCSF
San Francisco, California, United States
Dr. Katerina Akassoglou is a Senior Investigator at the Gladstone Institutes and a Professor of Neurology at UCSF. She has pioneered studies on neurovascular regulation of inflammation and tissue repair and the molecular interface blood proteins utilize to interact with nervous system cells. She discovered that fibrinogen is a key vascular-derived culprit for triggering pathogenic neuroinflammation to promote neuronal toxicity and inhibit myelin repair. She developed a first-in-class fibrin-targeting immunotherapy to protect the brain from pathogenic neuroinflammation in neurological diseases, such as multiple sclerosis and Alzheimer’s disease. She has published over 100 papers and book chapters. Dr. Akassoglou is a named inventor on 11 issued and several pending patents and the scientific founder of the university spin-out Therini Bio. Dr. Akassoglou was awarded by the White House the Presidential Early Career Award for Scientists and Engineers, the John J. Abel Award in Pharmacology, the Dana Foundation Award, a EUREKA and R35 Research Program Award from NIH, The Marilyn Hilton Award for Innovation in MS Research, the Barancik Prize, the ISFP Prize and she was named by the San Francisco Business Times among the 2021 Most Influential Women in Bay Area Business. Dr. Akassoglou is a Fellow of the American Neurological Association (ANA) and elected Fellow of the National Academy of Inventors (NAI), the American Society for Pharmacology and Experimental Therapeutics (ASPET) and Lifetime Fellow of the American Association for the Advancement of Science (AAAS).
PL 02.1 - Role of Fibrinogen in Neurodegenerative Disease
Sunday, June 25, 2023
09:30 – 10:15 ET